News
NGT BioPharma Consultants Welcomes Roger Nosal. Prior to September 2022 he was Vice President & Head of Global Chemistry, Manufacturing & Controls at Pfizer where...
NGT BioPharma Consultants Welcomes Jim Weber, Strategist CMC
NGT BioPharma Consultants Welcomes Daniel Schaufelberger, VP CMC and Specialist in Pediatric Drug Development.
NGT BioPharma Consultants Welcomes Michelle McGuinness, VP Regulatory Strategy & Submissions
NGT BioPharma's Dr. Robert Dennehy is appointed to Strategic Advisory Board at CatSci.
Our people are at the core of our business. We are featuring the amazing individuals who make NGT BioPharma Consultants a proficient and principled team to work with. Today...
Our people are at the core of our business. We are featuring the amazing individuals who make NGT BioPharma Consultants a proficient and principled team to work with. Today...
Listen to NGT’s API Expert Malcolm Berry at the Pharma 4.0 eConference!
While the world focuses on COVID-19, NGT’s Michael K. O’Brien and Philip Chu provide insight on the current state of the market for antimicrobial resistant (AMR) medicines....
12
Page 1 of 2
